9min chapter

The HemOnc Pulse cover image

Discussing the Role of MRD in CLL With Talal Hilal, MD

The HemOnc Pulse

CHAPTER

Exploring the Impact of MRD in CLL Treatment

The chapter delves into the considerations surrounding the use of Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL) treatment, discussing the challenges, tools like flow cytometry and NGS, and tailoring testing based on treatment types. It emphasizes the significance of MRD in treatment decisions, citing a UK study focusing on MRD-guided treatments to achieve undetectable MRD levels and deeper disease eradication.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode